In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
In today's ACT Brief, we explore the leadership priorities that enable meaningful AI gains in clinical research, how Bayesian methodologies are reshaping trial design and innovation, and proposed ...
Researchers have proposed an efficient feature search approach for estimating the state of health of lithium-ion batteries, ...
To address the limitations of binary pCR classification, Pusztai and colleagues developed the residual cancer burden (RCB) ...
(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...
Scientists have quantified what draws mosquitoes to people—which could help make better, life-saving bug traps.
Advances in artificial intelligence promise to help chemical engineers discover complex new materials. These materials could ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
The Antikythera mechanism has been described as the world’s first analogue computer since it was found in a shipwreck off the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results